Traditional funding

2012: Promising Year for Life Sciences Industry 23 December 2011

Private investments in life sciences will exceed around 10 percent in 2012. Traditional funding by venture capitals, angel capitals, and other private sources of funding will continue to be the major sources of investments. Traditional venture investors will be funding...

Keywords: uncertainty with regulatory issues, biotech visionary, biotech visionary, IPO activity

Read More